UMLS. CSP-HL7-ICD9CM-NCI-NDFRT-RXNORM
%
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
E E0 E6 E7 EA EB EC ED EE EF EG EH EI EJ EK EL EM EN EO EP EQ ER ES ET EU EV EW EX EY
EP- EP4 EPA EPE EPH EPI EPM EPN EPO EPP EPR EPS EPT
selected terms: 276 page 1 of 3

1. (-)-Ephedrine
[alpha- and beta-adrenergic agonist that may also enhance release of norepinephrine; has been used in the treatment of several disorders including asthma, heart failure, rhinitis, and urinary incontinence, and for its central nervous system stimulatory effects in the treatment of narcolepsy and depression. ( CSP )] (UMLS (NCI) C0014479) =Organic Chemical; Pharmacologic Substance ;
=adrenergic agent;
bronchodilator;
Phenethylamines;
Propanolamines;
[AU100] SYMPATHOMIMETICS (ADRENERGICS);
[RE103] BRONCHODILATORS, SYMPATHOMIMETIC,ORAL =PSEUDOEPHEDRINE;
cinnamedrine;
EPHEDRINE HYDROCHLORIDE;
EPHEDRINE SULFATE;
EPHEDRINE TANNATE;
EPHEDRINE HYDROCHLORIDE;
EPHEDRINE SULFATE;
EPHEDRINE TANNATE;
51. EPIDEM KERATOCONJUNCTIV
(UMLS (ICD9CM) C0014493) =Disease or Syndrome ;
2. (-)-Epigallocatechin 3-gallate
[A phenolic antioxidant found in a number of plants such as green and black tea. It inhibits cellular oxidation and prevents free radical damage to cells. It is under study as a potential cancer chemopreventive agent. (NCI) ( NCI )] (UMLS (NCI) C0059438) =Organic Chemical; Pharmacologic Substance ;
52. epidemic
[ ] (UMLS (CSP) C0014499) =Phenomenon or Process ;
3. (-)-Epothilone B
[A substance that is being studied as a treatment for cancer. It belongs to the family of drugs called epothilones. Also called EPO906. ( NCI )] (UMLS (NCI) C0297960) =Organic Chemical; Pharmacologic Substance
53. epidemic hemorrhagic fever virus
[The type species of the genus HANTAVIRUS infecting the rodent Apodemus agrarius and humans who come in contact with it. It causes syndromes of hemorrhagic fever associated with vascular and especially renal pathology. ( MSH )] (UMLS (CSP) C0086384) =Virus
4. (2E)-5-[3-[(Phenylsufonyl) Aminol Phenyl]-pent-2-en-4-ynohydroxamic Acid
[An inhibitor of histone deacetylase. It is an aromatic sulfonamide hydroxamate initially found in a screen for inhibitors of the tumorigenic phenotype of K-ras-transformed NIH3T3 cells. ( NCI )] (UMLS (NCI) C0391491) =Organic Chemical; Pharmacologic Substance ;
54. EPIDEMIC PLEURODYNIA
[An acute, febrile, infectious disease generally occurring in epidemics. It is usually caused by coxsackieviruses B and sometimes by coxsackieviruses A; echoviruses; or other enteroviruses. ( MSH )] (UMLS (ICD9CM) C0032238) =Disease or Syndrome ;
=Coxsackievirus Infections;
5. 1,2-Epoxyethane
[Colorless, odorless, flammable, toxic gaseous cyclic ether with a sweet ether-like smell. Ethylene oxide is used especially in the synthesis of ethylene glycol and as a sterilizing agent for medical supplies and foods, as a fumigant and as an insecticide. Exposure to this substance is highly irritating to the eyes, skin and respiratory tract, induces nausea and vomiting and causes central nervous system depression. Ethylene oxide is mutagenic in humans and chronic exposure is associated with an increased risk of leukemia, stomach cancer, pancreatic cancer and non-Hodgkin's lymphoma. (NCI05) ( NCI )] (UMLS (NCI) C0015087) =Organic Chemical; Hazardous or Poisonous Substance ;
=epoxide;
55. EPIDEMIC VERTIGO
[ ] (UMLS (ICD9CM) C0155508) =Disease or Syndrome ;
6. 1,2-Epoxyethylbenzene
[A synthetic, colorless liquid that is very soluble in water. Styrene oxide is used as a chemical intermediate in the production of styrene glycol and its derivatives, cosmetics, surface coatings and other chemicals (agricultural and biological). It is also used as a reactive diluent for epoxy resins and in cross-linked polyesters and polyurethanes. Humans in the general population may be exposed to styrene oxide by contact with contaminated air or water. It is reasonably anticipated to be a human carcinogen. (NCI05) ( NCI )] (UMLS (NCI) C0075351) =Organic Chemical
56. EPIDEMIC VOMITING SYND
(UMLS (ICD9CM) C0014498) =Disease or Syndrome ;
7. 1,2-Epoxypropane
[A synthetic, highly-flammable, volatile, colorless liquid that is soluble in water and miscible with many organic solvents. Propylene oxide is used primarily as a chemical intermediate in the production of polyethers and propylene glycol. It is also used as a pesticide and a fumigant for the sterilization of packaged foods and plastic medical instruments. Acute inhalation exposure to vapors of this compound can result in respiratory tract irritation, coughing, difficulty in breathing (dyspnea) and buildup of fluid in the lungs (pulmonary edema) that can possibly lead to pneumonia. Inhale high concentrations of the vapors for short time periods may cause headache, motor weakness, incoordination, ataxia and coma. Contact with propylene oxide can irritate the eyes and skin. It is reasonably anticipated to be a human carcinogen. (NCI05) ( NCI )] (UMLS (NCI) C0072229) =Organic Chemical
57. Epidemiologic
[The study of the incidence, causes, spread, prevention, and control of disease in a population. ( NCI )] (UMLS (NCI) C0014507) =Biomedical Occupation or Discipline ;
8. 1,4-Epoxy-1,3-butadiene
[compounds with a 5-membered ring of four carbons and an oxygen; aromatic heterocycles; the reduced form is tetrahydrofuran. ( CSP )] (UMLS (NCI) C0060850) =Organic Chemical =oxygenous heterocyclic compound;
=benzofuran;
N-[2-[[[5-[(Dimethylamino)methyl]-2-furanyl]methyl]thio]ethyl]-N'-methyl-2-nitro-1,1-ethenediamine
58. Epidemiologic Research
[The study of factors determining and influencing the frequency and distribution of disease, injury, and other health related events and their causes in a defined human population. (CSP2000) ( NCI )] (UMLS (NCI) C0002783) =Research Activity
9. 1-Epoxyethyl-3,4-epoxycyclohexane
[A synthetic, colorless liquid that is soluble in water. It is used as a reactive diluent for other epoxides and as a monomer in the production of epoxy resins for coatings and adhesives. Occupational exposure of humans to 4-vinyl-1-cyclohexene diepoxide results in skin irritation. It is reasonably anticipated to be a human carcinogen. (NCI05) ( NCI )] (UMLS (NCI) C0048737) =Organic Chemical; Hazardous or Poisonous Substance ;
59. Epidemiological Method
[Epidemiological methods involve sophisticated statistics and higher mathematics. These methods allow epidemiologists to address issues like non-experimental studies of mechanistic questions in disease etiology, including studies of the impact of the social position of individuals in different social contexts. ( NCI )] (UMLS (NCI) C0014503) =Research Activity ;
10. 15,19-Epoxy-3H-pyrido(2,1-c)(1,4)oxaazacyclotricosine-1,7,20,21(4H,23H)-tetrone, 3-((1E)-2-((1R,3R,4S)-4-chloro-3-methoxycyclohexyl)-1-methylethenyl)-8-ethyl-5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-hexadecahydro-5,19-dihydroxy-14,16-dimethoxy-4,10,1
[A 33-epi-chloro-derivative of the ascomycin macrolactam with immunosuppressant property. Pimecrolimus binds to the receptor macrophilin-12 (FKBP-12) forming a complex that blocks the calcium-dependent signal transduction cascade mediated by calcineurin. Via dephosphorylation, calcineurin is the enzyme responsible for activating nuclear factor of activated T-cells (NF-AT), a T cell transcriptional regulatory factor. As a consequence, the synthesis and release of Th1- (T helper 1) and Th2- (T helper 2) type cytokines, and other inflammatory mediators from T-cells and mast cells are blocked and the expression of signals essential for the activation of inflammatory T-lymphocytes is inhibited. However, pimecrolimus mode of action is cell-selective and does not affect Langerhans' cells/dendritic cells and primary fibroblasts. ( NCI )] (UMLS (NCI) C1099414) 33-epi-Chloro-33-desoxyascomycin;
PIMECROLIMUS;
PIMECROLIMUS UNIDENTIFIED;
PIMECROLIMUS PREPARATION;
PIMECROLIMUS UNIDENTIFIED =Organic Chemical; Pharmacologic Substance =[DE900] DERMATOLOGICALS, TOPICAL OTHER;
Unclassified Ingredients =PIMECROLIMUS 1 %
60. epidemiology
[study of factors determining and influencing the frequency and distribution of disease, injury, and other health related events and their causes in a defined human population. ( CSP )] (UMLS (CSP) C0699910) =Health Care Activity ;
=human population study;
=diathesis;
communicable disease transmission;
disease onset;
cardiovascular disorder epidemiology;
mental health epidemiology;
neoplasm/cancer epidemiology;
nervous system disorder epidemiology;
respiratory disorder epidemiology;
substance abuse epidemiology;
Communicable Diseases, Emerging;
nutritional epidemiology
11. 2,3-Epoxy-1-propanol
[Slightly viscous, colorless and odorless liquid cyclic ether. Glycidol is used as a stabilizer for natural oils and vinyl polymers, as an alkylating agent, a sterilant, a demulsifier, a dye-leveling agent and it is also used as an intermediate in the synthesis of glycerol, glycidyl ethers and amines. Exposure to Glycidol irritates the skin, eyes, and mucous membranes and depresses the central nervous system in humans. Glycidol induces mutations in human lymphocytes and is reasonably anticipated to be a human carcinogen. (NCI05) ( NCI )] (UMLS (NCI) C0061587) =Organic Chemical; Indicator, Reagent, or Diagnostic Aid ;
61. Epidemiology / Surveillance
[The systematic collection, analysis, and interpretation of health data on an ongoing basis. ( NCI )] (UMLS (NCI) C0733511) Surveillance =Health Care Activity
12. 4,5-Epoxy-14-hydroxy-3-methoxy-17-methylmorphinan-6-one
[A semi-synthetic, morphine-like opioid alkaloid with analgesic activity. Oxycodone exerts its analgesic activity by binding to the mu-receptors in the central nervous system (CNS), thereby mimicking the effects of endogenous opioids. Binding of the opiate receptor stimulates the exchange of GTP for GDP on the G-protein complex and inhibits adenylate cyclase, thereby preventing cAMP production. Subsequently, the release of nociceptive neurotransmitters, such as substance P, gamma-aminobutyric acid (GABA), dopamine, acetylcholine, and noradrenaline, is inhibited. Oxycodone also inhibits the release of vasopressin, somatostatin, insulin, and glucagon. In addition, oxycodone closes N-type voltage-gated calcium channels and opens G-protein-coupled inwardly rectifying potassium channels resulting in hyperpolarization and reduction of neuronal excitability. ( NCI )] (UMLS (NCI) C0030049) =Organic Chemical; Pharmacologic Substance =[CN101] OPIOID ANALGESICS;
codeine =4,5alpha-Epoxy-14-hydroxy-3-methoxy-17-methylmorphinan-6-one Hydrochloride;
Oxycodone Terephthalate;
4,5alpha-Epoxy-14-hydroxy-3-methoxy-17-methylmorphinan-6-one Hydrochloride;
Oxycodone Terephthalate;
OXYCODONE 5 MG;
62. Epidemiology Molecular
[The application of molecular biology techniques in answering epidemiological questions. ( NCI )] (UMLS (NCI) C0206173) =Biomedical Occupation or Discipline
13. 6,7-Epoxytropine Tropate
[A toluidine derivative and intermediate-acting amino amide with local anesthetic property. Prilocaine stabilizes the neuronal membrane by preferential binding to and inhibiting depolarization of the voltage-gated sodium channel. This results in a decrease in membrane permeability and subsequent inhibition of the ionic sodium influx required for the initiation and conduction of impulses. ( NCI )] (UMLS (NCI) C0033124) =Organic Chemical; Pharmacologic Substance =Anilides;
[CN204] LOCAL ANESTHETICS, INJECTION =2-(Propylamino)-o-propionotoluidide Hydrochloride;
PRILOCAINE 2.5 %
63. Epidemiology, Family Medical History
[A record of a patient's background regarding health and disease events of blood relatives. A patients family medical history may be important in diagnosing existing conditions. (NCI) ( NCI )] (UMLS (NCI) C0241889) =Finding
14. E protein
[ ] (UMLS (CSP) C0599561) =Amino Acid, Peptide, or Protein; Biologically Active Substance
64. Epidemiology, Genetic
[Interdisciplinary clinical, epidemiologic, genetic, and laboratory studies of persons, families, and populations at high risk of cancer. These investigations identify genes and exposures conferring cancer predisposition, and explore the combined effects of predisposition and specific exposures. (from DCEG homepage) ( NCI )] (UMLS (NCI) C0872180) genetic epidemiology;
=Occupation or Discipline ;
15. EP-2101
[A proprietary cancer DNA vaccine that contains multiple natural and modified epitopes derived from the four tumor associated antigens, CEA, HER2/neu, p53, and MAGE 2/3. EP-2101 also includes CAP1-6D, a heteroclitic CEA analog, and PADRE, a proprietary universal T-cell epitope that serves to enhance the immunogenicity of the epitopes. This agent has been shown to elicit cytotoxic T-lymphocyte responses against tumor cells expressing these multiple epitopes. (NCI04) ( NCI )] (UMLS (NCI) C1327951) =Pharmacologic Substance; ;
65. Epidermal
[(ep-i-DER-mis) The upper or outer layer of the two main layers of tissue that make up the skin. ( NCI )] (UMLS (NCI) C0014520) =Tissue ;
16. EP-2101/Montanide ISA-51
(UMLS (NCI) C1327959) =Therapeutic or Preventive Procedure; ;
66. Epidermal Growth Factor Receptor Kinase Substrate EPS8
[Epidermal growth factor receptor pathway substrate 8; has a role in normal and neoplastic cell proliferation; contains an SH3 motif. (LocusLink) ( NCI )] (UMLS (NCI) C1333332) Epidermal Growth Factor Receptor Pathway Substrate 8;
EPS8;
=Amino Acid, Peptide, or Protein; Biologically Active Substance
17. EP4
[Expressed in several tissues, including male reproductive system, respiratory tract, and nasopharynx as 5 alternatively spliced transcripts, human WFDC2 Gene (WFDC Family) encodes 5 secreted isoforms of Epididymal Secretory Protein E4 that contain one or two WFDC domains. The WFDC domain contains eight cysteines forming four disulfide bonds at the protein core and often functions in protease inhibition. WFDC2 may be involved in sperm maturation. (NCI) ( NCI )] (UMLS (NCI) C0903042) Epididymal Secretory Protein E4;
Epididymis-Specific Whey-Acidic Type Four-Disulfide Core Protein;
Major Epididymis-Specific Protein E4;
Putative Protease Inhibitor WAP5;
WAP Domain Containing Protein HE4-V4;
WAP Four-Disulfide Core Domain Protein 2;
WFDC2;
=Amino Acid, Peptide, or Protein; Biologically Active Substance ;
67. Epidermal Growth Factor Receptor Pathway Substrate 15 Gene
[This gene plays a role in signal transduction and cell proliferation. ( NCI )] (UMLS (NCI) C1333343) EPS15;
EPS15 Gene;
=Gene or Genome ;
18. EPA3
[The HEK receptor tyrosine kinase shows a high degree of homology with EPH and ELK RTKs. The largest subfamily of RTKs, EPH-related receptors have been implicated in mediating developmental events, particularly in the nervous system. EPH-family receptors typically have a single kinase domain and an extracellular region containing a Cys-rich domain and 2 fibronectin type III repeats. EPH receptors are divided into two groups based on their extracellular domain sequences and affinities for ephrin-A (EPHA) and ephrin-B ligands (EPHB). HEK expression appears restricted to lymphoid tumor cell lines, suggesting that HEK may contribute to lymphoid malignancies and normal lymphoid function and differentiation. (from OMIM 179611 and NCI) ( NCI )] (UMLS (NCI) C0121258) =Amino Acid, Peptide, or Protein; Enzyme; Receptor
68. Epidermal Growth Factor Receptor Pathway Substrate 8 Gene
[This gene is involved in signal transduction and cell proliferation. ( NCI )] (UMLS (NCI) C1333350) EPS8;
EPS8 Gene;
=Gene or Genome; ;
19. ependyma
[A thin membrane that lines the ventricles of the brain and the central canal of the spinal cord. ( NCI )] (UMLS (CSP) C0014472) =Tissue
69. Epidermal Growth Factor Receptor Pathway Substrate 8 Related Protein 1
[Epidermal Growth Factor Receptor Pathway Substrate 8-Like Protein 1, encoded by the EPS8L1 gene, is related to epidermal growth factor receptor pathway substrate 8 (EPS8), a substrate for the epidermal growth factor receptor. The function of this protein is unknown. Several alternatively spliced transcript variants encoding different isoforms exist. (LocusLink) ( NCI )] (UMLS (NCI) C1333344) Epidermal Growth Factor Receptor Pathway Substrate 8-Like Protein 1;
Epidermal Growth Factor Receptor Pathway Substrate 8-Related Protein 1;
EPS8L1;
EPS8-Like 1;
EPS8-Related Protein 1 =Amino Acid, Peptide, or Protein; Biologically Active Substance
20. Ependymal Cell
[A cell that lines cavities in the central nervous system. It is considered to be a type of glial cell. ( NCI )] (UMLS (NCI) C0228092) =Cell
70. Epidermal Growth Factor Receptor Pathway Substrate 8 Related Protein 3
[Epidermal Growth Factor Receptor Pathway Substrate 8-Like Protein 3, encoded by the EPS8L3 gene, is related to epidermal growth factor receptor pathway substrate 8 (EPS8), a substrate for the epidermal growth factor receptor. The function of this protein is unknown. (LocusLink) ( NCI )] (UMLS (NCI) C1333346) Epidermal Growth Factor Receptor Pathway Substrate 8-Like Protein 3;
Epidermal Growth Factor Receptor Pathway Substrate 8-Related Protein 3;
EPS8L3;
EPS8-Like 3;
EPS8-Related Protein 3 =Amino Acid, Peptide, or Protein; Biologically Active Substance
21. Ependymal Cyst
(UMLS (NCI) C0338599) =Finding
71. Epidermal Growth Factor Receptor Pathway Substrate 8-Like Protein 2
[Encoded by human EPS8L2 Gene, EPS8-Related Protein 2 is a protein of unknown function related to EGFR Pathway Substrate 8 (EPS8), a substrate for the EGFR. (NCI) ( NCI )] (UMLS (NCI) C1333345) Epidermal Growth Factor Receptor Pathway Substrate 8-Related Protein 2;
EPS8L2;
EPS8-Related Protein 2;
Hypothetical Protein FLJ22171;
=Amino Acid, Peptide, or Protein; Biologically Active Substance
22. Ependymal Neoplasm
[A type of brain tumor that usually begins in the central canal of the spinal cord. Ependymal tumors may also develop in the cells lining the ventricles of the brain, which produce and store the special fluid (cerebrospinal fluid) that protects the brain and spinal cord. Also called ependymomas. ( NCI )] (UMLS (NCI) C1333407) Ependymal Neoplasms;
Ependymal Tumor;
Ependymal Tumors;
=Neoplastic Process; ;
72. Epidermal Growth Factor Related Transforming Growth Factor
[Transforming growth factors (TGFs) are biologically active polypeptides that reversibly confer the transformed phenotype on cultured cells. Alpha-TGF shows about 40% sequence homology with epidermal growth factor and competes with EGF for binding to the EGF receptor, stimulating its phosphorylation and producing a mitogenic response (OMIM) ( NCI )] (UMLS (NCI) C0040688) =Amino Acid, Peptide, or Protein; Biologically Active Substance
23. Ependymal Neoplasm of Spinal Cord
(UMLS (NCI) C0238432) =Neoplastic Process
73. Epidermal Inclusion Cyst
(UMLS (NCI) C0259770) =Anatomical Abnormality
24. Ependymal Rosette Formation
(UMLS (NCI) C1333406) =Finding; ;
74. epidermal necrolysin
[ ] (UMLS (CSP) C0599426) =Pathologic Function
25. Ependymal Tumor of Brain
[A tumor arising from the ependymal lining of the ventricles. ( NCI )] (UMLS (NCI) C0238029) =Neoplastic Process ;
75. Epidermal Nevus
(UMLS (NCI) C0334082) =Congenital Abnormality
26. Ependymoblastoma
[An aggressive malignant embryonal neoplasm arising from the central nervous system. It is characterized by the presence of multilayered rosettes formation, and increased cellularity. Symptoms include increased intracranial pressure, hydrocephalus, and focal neurological signs. ( NCI )] (UMLS (NCI) C0700367) =Neoplastic Process
76. Epidermoid Cancer Metastatic to the Neck with Occult Primary
(UMLS (NCI) C0220635) =Neoplastic Process ;
27. ependymoma
[gliomas derived from ependymocytes that tend to present as malignant intracranial tumors in children and as benign intraspinal neoplasms in adults; may arise from any level of the ventricular system or central canal of the spinal cord; intracranial ependymomas most frequently originate in the fourth ventricle and histologically are densely cellular tumors which may contain ependymal tubules and perivascular pseudorosettes; spinal ependymomas are usually benign papillary or myxopapillary tumors. ( CSP )] (UMLS (NCI) C0014474) =Neoplastic Process =glial cell tumor;
=Glioma, Subependymal
77. Epidermoid Carcinoma in situ
[A malignant epithelial neoplasm confined to the squamous epithelium, without invasion of the underlying tissues. ( NCI )] (UMLS (NCI) C0334245) =Neoplastic Process
28. EPH
[The EPH and EPH-related receptors comprise the largest subfamily of receptor protein-tyrosine kinases. They are implicated in mediating developmental events, particularly in the nervous system. They typically have a single kinase domain and an extracellular region containing a Cys-rich domain and 2 fibronectin type III repeats. Their ligands are called ephrins. Based on structure and sequence relationships, ephrins are divided into the ephrin-A (EFNA) class, and the ephrin-B (EFNB) class. The Eph family of receptors are divided into 2 groups based on the similarity of their extracellular domain sequences and their affinities for binding ephrin-A and ephrin-B ligands. The Eph receptors interacting preferentially with ephrin-A proteins are called EphA and Eph receptors interacting preferentially with ephrin-B proteins are called EphB. (OMIM) ( NCI )] (UMLS (NCI) C0908506) Ephrin Receptor =Amino Acid, Peptide, or Protein; Enzyme; Receptor
78. Epidermoid Carcinoma in situ of Hypopharynx
(UMLS (NCI) C0862651) Epidermoid Carcinoma in situ of the Hypopharynx;
Hypopharyngeal Epidermoid Carcinoma in situ;
Hypopharyngeal Squamous Cell Carcinoma in situ;
Hypopharynx Epidermoid Carcinoma in situ;
Hypopharynx Squamous Cell Carcinoma in situ;
Squamous Cell Carcinoma in situ of Hypopharynx;
Squamous Cell Carcinoma in situ of the Hypopharynx;
Stage 0 Epidermoid Carcinoma of Hypopharynx;
Stage 0 Epidermoid Carcinoma of the Hypopharynx;
Stage 0 Hypopharyngeal Epidermoid Carcinoma;
Stage 0 Hypopharyngeal Squamous Cell Carcinoma;
Stage 0 Hypopharynx Epidermoid Carcinoma;
Stage 0 Hypopharynx Squamous Cell Carcinoma;
Stage 0 Squamous Cell Carcinoma of Hypopharynx;
Stage 0 Squamous Cell Carcinoma of the Hypopharynx =Neoplastic Process
29. EPH Receptor A1 Gene
[This gene is involved in the mediation of development in the nervous system. ( NCI )] (UMLS (NCI) C0812262) EPHA1;
EPHA1 Gene =Gene or Genome
79. Epidermoid Carcinoma in situ of Larynx
(UMLS (NCI) C1336090) Epidermoid Carcinoma in situ of the Larynx;
Laryngeal Epidermoid Carcinoma in situ;
Laryngeal Squamous Cell Carcinoma in situ;
Larynx Epidermoid Carcinoma in situ;
Larynx Squamous Cell Carcinoma in situ;
Squamous Cell Carcinoma in situ of Larynx;
Squamous Cell Carcinoma in situ of the Larynx;
Stage 0 Epidermoid Carcinoma of Larynx;
Stage 0 Epidermoid Carcinoma of the Larynx;
Stage 0 Laryngeal Epidermoid Carcinoma;
Stage 0 Laryngeal Squamous Cell Carcinoma;
Stage 0 Larynx Epidermoid Carcinoma;
Stage 0 Larynx Squamous Cell Carcinoma;
Stage 0 Squamous Cell Carcinoma of Larynx;
Stage 0 Squamous Cell Carcinoma of the Larynx =Neoplastic Process
30. EPH Receptor A2 Gene
[This gene plays a role in development and is upregulated in several breast carcinomas. ( NCI )] (UMLS (NCI) C1333337) EPHA2;
EPHA2 Gene;
=Gene or Genome ;
80. Epidermoid Carcinoma in situ of Mouth
(UMLS (NCI) C0861571) Epidermoid Carcinoma in situ of Oral Cavity;
Epidermoid Carcinoma in situ of the Mouth;
Epidermoid Carcinoma in situ of the Oral Cavity;
Mouth Epidermoid Carcinoma in situ;
Mouth Squamous Cell Carcinoma in situ;
Oral Cavity Epidermoid Carcinoma in situ;
Oral Cavity Squamous Cell Carcinoma in situ;
Squamous Cell Carcinoma in situ of Mouth;
Squamous Cell Carcinoma in situ of Oral Cavity;
Squamous Cell Carcinoma in situ of the Mouth;
Squamous Cell Carcinoma in situ of the Oral Cavity;
Stage 0 Epidermoid Carcinoma of Mouth;
Stage 0 Epidermoid Carcinoma of Oral Cavity;
Stage 0 Epidermoid Carcinoma of the Mouth;
Stage 0 Epidermoid Carcinoma of the Oral Cavity;
Stage 0 Mouth Epidermoid Carcinoma;
Stage 0 Oral Cavity Epidermoid Carcinoma;
Stage 0 Oral Cavity Squamous Cell Carcinoma;
Stage 0 Squamous Cell Carcinoma of Mouth;
Stage 0 Squamous Cell Carcinoma of Oral Cavity;
Stage 0 Squamous Cell Carcinoma of the Mouth;
Stage 0 Squamous Cell Carcinoma of the Oral Cavity;
=Neoplastic Process
31. EPH Receptor A3 Gene
[This gene is involved in receptor tyrosine kinase signal transduction and plays a role in lymphoid function and differentiation. ( NCI )] (UMLS (NCI) C0812263) EPHA3;
EPHA3 Gene =Gene or Genome
81. Epidermoid Carcinoma in situ of Oropharynx
(UMLS (NCI) C0861725) Epidermoid Carcinoma in situ of the Oropharynx;
Oropharyngeal Epidermoid Carcinoma in situ;
Oropharyngeal Squamous Cell Carcinoma in situ;
Oropharynx Epidermoid Carcinoma in situ;
Oropharynx Squamous Cell Carcinoma in situ;
Squamous Cell Carcinoma in situ of Oropharynx;
Squamous Cell Carcinoma in situ of the Oropharynx;
Stage 0 Epidermoid Carcinoma of Oropharynx;
Stage 0 Epidermoid Carcinoma of the Oropharynx;
Stage 0 Oropharyngeal Epidermoid Carcinoma;
Stage 0 Oropharyngeal Squamous Cell Carcinoma;
Stage 0 Oropharynx Epidermoid Carcinoma;
Stage 0 Oropharynx Squamous Cell Carcinoma;
Stage 0 Squamous Cell Carcinoma of Oropharynx;
Stage 0 Squamous Cell Carcinoma of the Oropharynx =Neoplastic Process
32. EPH Receptor A4 Gene
[This gene plays a role in neuronal development and in synaptic connections. ( NCI )] (UMLS (NCI) C1333338) EPHA4;
EPHA4 Gene;
=Gene or Genome ;
82. Epidermoid Carcinoma of Ethmoid Sinus
(UMLS (NCI) C1333477) Epidermoid Carcinoma of Ethmoidal Sinus;
Epidermoid Carcinoma of the Ethmoid Sinus;
Epidermoid Carcinoma of the Ethmoidal Sinus;
Ethmoid Sinus Epidermoid Carcinoma;
Ethmoid Sinus Squamous Cell Carcinoma;
Ethmoidal Sinus Epidermoid Carcinoma;
Ethmoidal Sinus Squamous Cell Carcinoma;
Squamous Cell Carcinoma of Ethmoid Sinus;
Squamous Cell Carcinoma of Ethmoidal Sinus;
Squamous Cell Carcinoma of the Ethmoid Sinus;
Squamous Cell Carcinoma of the Ethmoidal Sinus =Neoplastic Process ;
33. EPH Receptor A8 Gene
[This gene plays a role in axonal interactions in the nervous system. ( NCI )] (UMLS (NCI) C1333339) EPHA8;
EPHA8 Gene;
=Gene or Genome ;
83. Epidermoid Carcinoma of External Ear
(UMLS (NCI) C1333494) Epidermoid Carcinoma of the External Ear;
External Ear Epidermoid Carcinoma;
External Ear Squamous Cell Carcinoma;
Squamous Cell Carcinoma of External Ear;
Squamous Cell Carcinoma of the External Ear =Neoplastic Process ;
34. EPH Receptor B1 Gene
[This gene is involved in receptor tyrosine kinase signal transduction and development. ( NCI )] (UMLS (NCI) C1366441) EPHB1;
EPHB1 Gene =Gene or Genome
84. Epidermoid Carcinoma of Frontal Sinus
(UMLS (NCI) C1333646) Epidermoid Carcinoma of the Frontal Sinus;
Frontal Sinus Epidermoid Carcinoma;
Frontal Sinus Squamous Cell Carcinoma;
Squamous Cell Carcinoma of Frontal Sinus;
Squamous Cell Carcinoma of the Frontal Sinus =Neoplastic Process ;
35. EPH Receptor B2 Gene
[This gene plays a role in intracellular calcium regulation and spinal morphogenesis. ( NCI )] (UMLS (NCI) C1333340) EPHB2;
EPHB2 Gene;
=Gene or Genome ;
85. Epidermoid Carcinoma of Gallbladder
(UMLS (NCI) C0279658) =Neoplastic Process
36. EPH Receptor B3 Gene
[This gene is involved in cell-cell adhesion and cellular aggregation and plays a role in tyrosine kinase signal transduction. ( NCI )] (UMLS (NCI) C1333341) EPHB3;
EPHB3 Gene;
=Gene or Genome ;
86. Epidermoid Carcinoma of Glottis
(UMLS (NCI) C0280325) =Neoplastic Process
37. ephrin
[membrane bound signaling proteins; many are involved in control of morphogenic changes during embryogenesis. ( CSP )] (UMLS (CSP) C1136111) =Amino Acid, Peptide, or Protein; Biologically Active Substance =membrane protein;
cell communication molecule
87. Epidermoid Carcinoma of Hypopharynx
(UMLS (NCI) C0280321) =Neoplastic Process
38. EPHX1
[This gene is involved in both the activation and detoxification of xenobiotics. ( NCI )] (UMLS (NCI) C1134446) EPHX1 Gene;
Epoxide Hydrolase 1, Microsomal (Xenobiotic) Gene;
MEH =Gene or Genome ;
88. Epidermoid Carcinoma of Kidney Pelvis
(UMLS (NCI) C0238409) =Neoplastic Process
39. EPI/5-FU/MITO
(UMLS (NCI) C0083097) =Therapeutic or Preventive Procedure
89. Epidermoid Carcinoma of Lacrimal Gland
(UMLS (NCI) C1334360) Epidermoid Carcinoma of the Lacrimal Gland;
Lacrimal Gland Epidermoid Carcinoma;
Lacrimal Gland Squamous Cell Carcinoma;
Squamous Cell Carcinoma of Lacrimal Gland;
Squamous Cell Carcinoma of the Lacrimal Gland =Neoplastic Process ;
40. EPI/TAX
(UMLS (NCI) C0393029) =Therapeutic or Preventive Procedure
90. Epidermoid Carcinoma of Larynx
[A squamous cell carcinoma arising from the larynx. It is the most common type of laryngeal carcinoma. The site of origin within the larynx influences the symptoms, histologic characteristics, and clinical behavior of squamous cell carcinoma. The laryngeal squamous cell carcinomas can be glottic, supraglottic, and transglottic. Glottic carcinoma is the most frequent form of laryngeal carcinoma in the United States. Microscopically, squamous cell carcinomas of the larynx are similar in their appearance to squamous cell carcinomas arising elsewhere (adapted from Sternberg's Diagnostic Surgical Pathology, 3rd ed., 1999). —2002 ( NCI )] (UMLS (NCI) C0280324) =Neoplastic Process
41. EPI/VNB
(UMLS (NCI) C0338267) =Therapeutic or Preventive Procedure
91. Epidermoid Carcinoma of Maxillary Antrum
(UMLS (NCI) C1334647) Epidermoid Carcinoma of Maxillary Sinus;
Epidermoid Carcinoma of Maxillofacial Sinus;
Epidermoid Carcinoma of the Maxillary Antrum;
Epidermoid Carcinoma of the Maxillary Sinus;
Epidermoid Carcinoma of the Maxillofacial Sinus;
Maxillary Antrum Epidermoid Carcinoma;
Maxillary Antrum Squamous Cell Carcinoma;
Maxillary Sinus Epidermoid Carcinoma;
Maxillary Sinus Squamous Cell Carcinoma;
Maxillofacial Sinus Epidermoid Carcinoma;
Maxillofacial Sinus Squamous Cell Carcinoma;
Squamous Cell Carcinoma of Maxillary Antrum;
Squamous Cell Carcinoma of Maxillary Sinus;
Squamous Cell Carcinoma of Maxillofacial Sinus;
Squamous Cell Carcinoma of the Maxillary Antrum;
Squamous Cell Carcinoma of the Maxillary Sinus;
Squamous Cell Carcinoma of the Maxillofacial Sinus =Neoplastic Process ;
42. EPIANDROSTERONE
[A dehydroepiandrosterone metabolite and a precursor of testosterone and estradiol with hypolipidemic and anabolic property. Epiandrosterone, a potential neurosteroid, appears to bind to the gamma-aminobutyric acid (GABA)/benzodiazepine-receptor complex (GABA-RC), acting as a negative non-competitive modulator of GABA-RC as well as signal through the N-methyl-D-aspartate receptor. In addition this agent inhibits the pentose phosphate pathway (PPP) thereby dilating blood vessels pre-contracted by partial depolarization. Also, epiandosterone inhibits the synthesis of thromboxane A2 in activated platelets, reduces plasma plasminogen activator inhibitor type 1 and tissue plasminogen activator antigen, increases serum levels of insulin-like growth factor 1 and increases cyclic guanosine monophosphate and nitric oxide synthesis. These effects may improve circulation in the microvasculature. ( NCI )] (UMLS (NCI) C0014483) =Steroid; Hormone ;
92. Epidermoid Carcinoma of Middle Ear
(UMLS (NCI) C1334762) Epidermoid Carcinoma of the Middle Ear;
Middle Ear Epidermoid Carcinoma;
Middle Ear Squamous Cell Carcinoma;
Squamous Cell Carcinoma of Middle Ear;
Squamous Cell Carcinoma of the Middle Ear;
=Neoplastic Process
43. EPIC
[The determination of the number of epithelial cells in a sample. ( NCI )] (UMLS (NCI) C1273342) Epithelial Cell Count;
Epithelial Cells =Laboratory Procedure
93. Epidermoid Carcinoma of Minor Salivary Gland
(UMLS (NCI) C1334774) Epidermoid Carcinoma of the Minor Salivary Gland;
Minor Salivary Gland Epidermoid Carcinoma;
Minor Salivary Gland Squamous Cell Carcinoma;
Squamous Cell Carcinoma of Minor Salivary Gland;
Squamous Cell Carcinoma of the Minor Salivary Gland;
=Neoplastic Process ;
44. Epicardial
(UMLS (HL7) C0442016) =Spatial Concept =Body Part;
94. Epidermoid Carcinoma of Oropharynx
(UMLS (NCI) C0280313) =Neoplastic Process
45. Epicardial Lipoma
[A rare benign adipose tissue neoplasm of the epicardium of the heart. ( NCI )] (UMLS (NCI) C1333411) Lipoma of Epicardium;
Lipoma of the Epicardium =Neoplastic Process; ;
95. Epidermoid Carcinoma of Paranasal Sinus
(UMLS (NCI) C0280334) =Neoplastic Process
46. epicardial mapping
[ ] (UMLS (CSP) C0596531) =Diagnostic Procedure ;
=ECG;
96. Epidermoid Carcinoma of Penis
(UMLS (NCI) C0238348) =Neoplastic Process
47. Epicardial Neoplasm
(UMLS (NCI) C1290403) Epicardial Tumor;
Neoplasm of Epicardium;
Neoplasm of the Epicardium;
Tumor of Epicardium;
Tumor of the Epicardium =Neoplastic Process ;
97. Epidermoid Carcinoma of Postcricoid Area
(UMLS (NCI) C0280322) =Neoplastic Process
48. epicardium
[A single layer of squamous EPITHELIUM resting on a thin layer of loose CONNECTIVE TISSUE. ( MSH )] (UMLS (CSP) C0225968) =Tissue =Body Part;
98. Epidermoid Carcinoma of Pyriform Fossa
(UMLS (NCI) C0748214) Epidermoid Carcinoma of Pyriform Sinus;
Epidermoid Carcinoma of the Pyriform Fossa;
Epidermoid Carcinoma of the Pyriform Sinus;
Pyriform Fossa Epidermoid Carcinoma;
Pyriform Fossa Squamous Cell Carcinoma;
Pyriform Sinus Epidermoid Carcinoma;
Pyriform Sinus Squamous Cell Carcinoma;
Squamous Cell Carcinoma of Pyriform Fossa;
Squamous Cell Carcinoma of Pyriform Sinus;
Squamous Cell Carcinoma of the Pyriform Fossa;
Squamous Cell Carcinoma of the Pyriform Sinus =Neoplastic Process
49. Epicondylitis
(UMLS (NCI) C0014488) =Disease or Syndrome ;
99. Epidermoid Carcinoma of Salivary Gland
(UMLS (NCI) C0279697) =Neoplastic Process
50. EPICRANIAL SUBAPO HEMORR
[ ] (UMLS (ICD9CM) C0270092) =Injury or Poisoning
100. Epidermoid Carcinoma of Sphenoid Sinus
(UMLS (NCI) C1336039) Epidermoid Carcinoma of Sphenoidal Sinus;
Epidermoid Carcinoma of the Sphenoid Sinus;
Epidermoid Carcinoma of the Sphenoidal Sinus;
Sphenoid Sinus Epidermoid Carcinoma;
Sphenoid Sinus Squamous Cell Carcinoma;
Sphenoidal Sinus Epidermoid Carcinoma;
Sphenoidal Sinus Squamous Cell Carcinoma;
Squamous Cell Carcinoma of Sphenoid Sinus;
Squamous Cell Carcinoma of Sphenoidal Sinus;
Squamous Cell Carcinoma of the Sphenoid Sinus;
Squamous Cell Carcinoma of the Sphenoidal Sinus =Neoplastic Process ;

Buy website

Medical Clinic. Optician. Pharmacy. Physician. Travel Agency. Hotel reservation. Child Care. Education. Teachers. Lessons. Tests and Exams. Certification. Shopping Center. Store. Real Estate.
Affordable prices from $100.


 home Dictionaries Armenian-English English-Armenian MeSH Feedback  top
© 2008 -2011 Administrator MEDINDEX.AM